ALC Alcon Inc.

Alcon Debuts Groundbreaking PRECISION7, a One-Week Replacement Contact Lens to Start and End Every Week Fresh

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. launch of PRECISION7®, the only one-week replacement contact lens with the revolutionary 7-day ACTIV-FLO® System2 that provides 16 hours of outstanding comfort and precise vision, even on day 7.1

While nearly nine out of ten Eye Care Professionals (ECPs) believe daily disposable lenses are better overall for their patients, more than half of new patients are still being fit in reusable lenses due to cost considerations.3* Most optometrists agree that a one-week contact lens replacement schedule would be more intuitive for patients, as compared to a two-week replacement schedule.4 PRECISION7 offers a breakthrough in comfort performance and an easy to remember replacement schedule when daily disposables are not an option.1,3-4*

“We are making history with the bold innovation of PRECISION7,” said Max Wolf, General Manager, Head of Vision Care and Contact Lenses at Alcon. “Now, patients can start and end every week fresh with a first-of-its-kind contact lens featuring ACTIV-FLO technology.1-2 This is also the first time we are introducing both sphere and toric lenses to the U.S. market simultaneously, allowing ECPs to address the needs of the majority of patients right away.”

The groundbreaking innovation of the ACTIV-FLO System in PRECISION7 is a unique combination of a water-loving moisturizing agent embedded in the lens matrix and a proprietary replenishing agent that is continually released to moisturize the surface for 7 days.2,5

“Data show that three out of every four contact lens wearers want their ECPs to talk to them about new contact lens technology,” said Jason Compton, OD, FAAO.6** “When daily disposable lenses aren’t an option, PRECISION7 provides 16 hours of outstanding comfort and precise vision, even on day 7, at a price our patients can afford.1,3 It has an easy and intuitive replacement schedule4 that allows my patients to pick their preferred day of the week to replace their contact lenses.”

The launch of PRECISION7 marks the newest addition to the Alcon WaterInnovations™ portfolio of contact lenses. Patients can experience PRECISION7 sphere and toric lenses through select ECPs effective immediately in the U.S. PRECISION7 will be more broadly commercially available in the U.S. beginning in January of 2025, with markets outside of the U.S. to follow later. See product instructions for complete wear, care, and safety information. For more information, please visit .

About Alcon

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at .

About WaterInnovations Contact Lenses

The Alcon WaterInnovations portfolio of contact lenses harnesses the power of water to deliver comfort for how we use our eyes today1,7-9, helping to outsmart Digital Device Dryness and many other challenges today’s patients face. PRECISION7 is the latest contact lens in Alcon’s WaterInnovations contact lens portfolio, joining additional proprietary lenses DAILIES TOTAL1®, PRECISION1®, and TOTAL30®.

References

  1. In a 2-week prospective clinical study in the US; n=181; CLEAR CARE Cleaning & Disinfecting Solution used for cleaning and disinfection; Alcon data on file, 2023.
  2. Zheng Y, Dou J, Wang Y, et al. Sustained release of a polymeric wetting agent from a silicone-hydrogel contact lens material. ACS Omega. 2022;7(33):29223-29230. doi: 10.1021/acsomega.2c03310.
  3. Alcon data on file, 2022.
  4. Based on a survey of 500 US optometrists who fit contact lenses; Alcon data on file, 2023.
  5. Phan CM, Chan VWY, Drolle E, et al. Evaluating the in vitro wettability and coefficient of friction of a novel and contemporary reusable silicone hydrogel contact lens materials using an in vitro blink model. Cont Lens Anterior Eye. 2024.
  6. Based on a survey of 500 US bi-weekly contact lens wearers; Alcon data on file, 2023.
  7. Fogt J, Patton K. Long day wear experience with water surface daily disposable contact lenses. ClinOptom. 2022(14):93-99.
  8. Perez-Gomez I, Giles T. European survey of contact lens wearers and eye care professionals on satisfaction with a new water gradient daily disposable contact lens. ClinOptom. 2014;6:17-23.
  9. In a clinical study wherein patients (n=66) used AOSEPT solution for nightly cleaning, disinfecting, and storing; Alcon data on file, 2021.

*Based on agreement with the statement "I believe daily disposable lenses are better for my patients overall.”

**Based on survey of 500 US bi-weekly contact lens wearers.

Connect with us on



EN
07/11/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Alcon Inc.

 PRESS RELEASE

Alcon Agrees to Acquire LENSAR, Inc.

GENEVA, Switzerland & ORLANDO, Fla.--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and LENSAR, Inc. (NASDAQ: LNSR), a global medical technology company focused on advanced laser solutions for the treatment of cataracts, today announced the companies have entered into a definitive merger agreement through which Alcon intends to acquire LENSAR. The acquisition includes ALLY Robotic Cataract Laser Treatment System™, LENSAR’s proprietary Streamline® software technology and LENSAR legacy laser system, building Alcon’s femtosecond...

 PRESS RELEASE

Alcon to Host 2025 Capital Markets Day

GENEVA--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care, will host its 2025 Capital Markets Day on March 27, 2025, beginning at 8:00 a.m. CT. A live webcast of the event will be available at the following link: . Those wishing to participate should register and log on approximately 10 minutes before the start of the webcast. About Alcon Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care product...

 PRESS RELEASE

Alcon Canada renforce son engagement envers les patients atteints d’as...

TORONTO--(BUSINESS WIRE)-- Alcon (SIX/NYSE : ALC), le chef de file mondial en matière de soins oculaires qui se consacre à aider les gens à voir avec clarté, a annoncé aujourd’hui l’ajout de paramètres élargis à la gamme de lentilles TOTAL30MD pour l’astigmatisme, les premières et les seules lentilles cornéennes toriques à remplacement mensuel avec gradient d’eau1-3 qui procurent la même expérience de port exceptionnellement confortable5, maintenant offertes avec une puissance cylindrique de -2,75 D. Ce communiqué de presse contient des éléments multimédias. Voir le communiqué complet ici : L...

 PRESS RELEASE

Alcon Canada Strengthens its Commitment to Astigmatic Patients with TO...

TORONTO--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the availability of expanded parameters for TOTAL30® for Astigmatism, the first and only monthly replacement Water Gradient toric contact lens,1-3 delivering the same exceptionally comfortable wearing experience,5 now in a –2.75D cylinder offering. This press release features multimedia. View the full release here: TOTAL30 for Astigmatism, the first and only monthly replacement Water Gradient toric contact lens, is now available in expanded parameters. (...

 PRESS RELEASE

Alcon Reports Full-Year 2024 Results, with Strong Top-line and Earning...

GENEVA--(BUSINESS WIRE)-- Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three and twelve month periods ending December 31, 2024. For the fourth quarter of 2024, sales were $2.5 billion, an increase of 6% on a reported and constant currency basis1, as compared to the same quarter of the previous year. Alcon reported diluted earnings per share of $0.57 and core diluted earnings per share2 of $0.72 in the fourth quarter of 2024. "In 2024, our unwavering focus on innovation and operational excellence delivered another set of strong results," said Dav...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch